Results 111 to 120 of about 12,086 (222)

Spermatozoon-propelled microcellular submarines combining innate magnetic hyperthermia with derived nanotherapies for thrombolysis and ischemia mitigation

Journal of Nanobiotechnology
Thrombotic cardiovascular diseases are a prevalent factor contributing to both physical impairment and mortality. Thrombolysis and ischemic mitigation have emerged as leading contemporary therapeutic approaches for addressing the consequences of ischemic
Pei-Wei Weng, Chia-Hung Liu, Pei-Ru Jheng, Chia-Che Chiang, Yan-Ting Chen, Lekshmi Rethi, Yves S. Y. Hsieh, Andrew E.-Y. Chuang   +7 more
doaj   +1 more source

Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. [PDF]

, 2009
BACKGROUND AND PURPOSE: Intracranial hemorrhage is a serious complication of thrombolytic therapy for acute myocardial infarction, especially among the elderly, but little information exists on estimating risk.
Lichtman, Judith H., Gurwitz, Jerry H., Radford, Martha J., Wang, Yun, Krumholz, Harlan M., Brass, Lawrence M.   +5 more
core  

In vitro evaluation of the anticoagulant and thrombolytic properties of Ehretia microphylla (tsaang gubat) leaves extract [PDF]

The study aimed to evaluate the in vitro anticoagulant and thrombolytic properties of Ehretia microphylla (tsaang gubat) ethanolic leaf extract using human blood samples.
Tampis, Hannah Naomi E., Pangan, Jazteen Kate D., Capulong, Chanely Isobel M., Gaa, Christine Joyce R., Macaraeg, Eric Cyril L., Amposta, Yekaterina Lindsay S.   +5 more
core  

Labeling of the Recombinant Streptokinase Using Iodine-131 as a New Thrombolytic Agent [PDF]

Stroke and acute myocardial infarction is a disease with the highest mortality in the world. WHO has estimated in 2008, 30% of deaths from heart disease and more than 80% of this cases have been occurred in developing countries.
I. Daruwati
core  

Thrombolysis for pulmonary embolism: A network meta-analysis. [PDF]

J Intensive Care Soc
Ross A, Glaister P, Robinson N, Crossingham I.   +3 more
europepmc   +1 more source

Advances in Reperfusion Therapy and Cytoprotection for Acute Ischemic Stroke. [PDF]

J Cardiovasc Dev Dis
Li Z, Wang C.
europepmc   +1 more source

Prognostic nomogram for acute cerebral infarction based on risk factors: treatment with urinary kallidinogenase and edaravone-dexborneol. [PDF]

Am J Transl Res
Ma F, Xu D, Xu Y, Wei L, Li H.
europepmc   +1 more source

Sequential Systemic Thrombolysis for Clot-In-Transit after Thrombolytic Failure in Massive Pulmonary Embolism. [PDF]

Eur J Case Rep Intern Med
MacCready E, Afriyie-Ansah S, Kwakye AO, Boaheng R.   +3 more
europepmc   +1 more source

Pharmacological evaluation of Adenostemma lavenia acetone extract in Swiss Albino mice: Analgesic, anti-inflammatory, and thrombolytic insights from in vivo, in vitro, density functional theory, and molecular docking studies. [PDF]

Animal Model Exp Med
Moon NJ, Mohammad M, Mamun MJI, Nova FBA, Eshaque NH, Rasel MH, Islam Z, Hasan MM, Ali ML, Chowdhury MT, Hossen SMM.   +10 more
europepmc   +1 more source

Real-world efficacy and safety of Tenecteplase versus Alteplase in acute ischemic stroke: a propensity score-matched analysis. [PDF]

Front Neurol
Zhang P, Sun L, Wang L.
europepmc   +1 more source